ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,085, issued on July 7, was assigned to OMIDEON Ltd. (St. Andrews, Great Britain).

"CBM uses" was invented by Graeme Rogers (St. Andrews, Great Britain) and Helen Connaris (St. Andrews, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides molecules which modulate cell growth. These molecules include those that bind carbohydrates and may find application in the treatment and/or prevention of cell proliferation and/or differentiation disorders, cancer and/or it's migration and/or spread."

The patent was filed on Jan. 24, 2020, under Application No. 17/425,374.

*For further information, including images, charts a...